2 weeks Ago By ABMN Staff
Clover Health Investments, Corp. ( NASDAQ:CLOV – Free Report ) – Stock analysts at Leerink Partnrs increased their FY2024 earnings per share (EPS) estimates for shares of Clover Health Investments in a research report issued on Wednesday, November 6th. Leerink Partnrs analyst W.
Mayo now expects that the company will earn ($0.12) per share for the year, up from their prior forecast of ($0.13).
The consensus estimate for Clover Health Investments’ current full-year earnings is ($0.12) per share. Leerink Partnrs also issued estimates for Clover Health Investments’ Q1 2025 earnings at ($0.
03) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.
07) EPS, FY2026 earnings at $0.05 EPS, FY2027 earnings at $0.10 EPS and FY2028 earnings at $0.
17 EPS. Separately, UBS Group started coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They issued a “neutral” rating and a $4.
00 price objective for the company. Clover Health Investments Stock Performance CLOV opened at $3.25 on Monday.
The company has a market cap of $1.62 billion, a PE ratio of -16.65 and a beta of 2.
03. Clover Health Investments has a 1 year low of $0.61 and a 1 year high of $4.
71. The firm has a 50 day moving average price of $3.48 and a 200 day moving average price of $2.
21. Clover Health Investments ( NASDAQ:CLOV – Get Free Report ) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.
02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01.
The company had revenue of $330.99 million during the quarter, compared to analyst estimates of $347.60 million.
Clover Health Investments had a negative return on equity of 26.33% and a negative net margin of 5.92%.
During the same period in the prior year, the firm posted ($0.09) earnings per share. Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently modified their holdings of CLOV.
Jupiter Asset Management Ltd. raised its holdings in shares of Clover Health Investments by 18.1% during the 1st quarter.
Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock valued at $3,593,000 after buying an additional 692,878 shares during the period. XTX Topco Ltd purchased a new stake in shares of Clover Health Investments during the second quarter valued at approximately $932,000.
Choreo LLC acquired a new position in shares of Clover Health Investments during the second quarter worth $344,000. Foundations Investment Advisors LLC purchased a new position in shares of Clover Health Investments in the third quarter valued at $55,000. Finally, Marshall Wace LLP acquired a new stake in Clover Health Investments during the 2nd quarter valued at $55,000.
Institutional investors and hedge funds own 19.77% of the company’s stock. About Clover Health Investments ( Get Free Report ) Clover Health Investments, Corp.
provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Recommended Stories Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter ..
